A Smartphone for adjustment of basal insulin dose and for coaching: benefits in terms of glycaemic control for type 2 diabetes patients

被引：0
|
作者：
Daoudi, A. [1 ]
Joubert, M. [2 ]
Franc, S. [1 ,3 ]
Fagour, C. [4 ]
Benhamou, P-Y [5 ]
Reznik, Y. [2 ]
Rodier, M. [6 ]
Boucherie, B. [1 ]
Benamo, E. [7 ]
Schaepelynck, P. [8 ]
Guerci, B. [9 ]
Dardari, D. [1 ]
Penfornis, A. [10 ]
Charpentier, G. [1 ,3 ]
机构：
[1] CERITD, Evry, France
[2] CHU Caen, Caen, France
[3] Ctr Hosp Sud Francilien, Corbeil Essonnes, France
[4] CHU Ft De France, Fort De France, France
[5] CHU Grenoble, Grenoble, France
[6] CHU Nimes, Nimes, France
[7] Ctr Hosp Henri Duffaut, Avignon, France
[8] CHU Marseille, Marseille, France
[9] CHU Nancy, Nancy, France
[10] CHU Besancon, Besancon, France
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1061
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [31] Switching to insulin glargine 300 U/ml in patients with type 2 diabetes on basal insulin supported oral therapy (BOT) improves glycaemic control
    Seufert, J.
    Fritsche, A.
    Anderten, H.
    Pegelow, K.
    Pscherer, S.
    Pfohl, M.
    DIABETOLOGIA, 2018, 61 : S441 - S441
  • [32] Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
    De Mattia, G.
    Laurenti, O.
    Moretti, A.
    ACTA DIABETOLOGICA, 2009, 46 (01) : 67 - 73
  • [33] Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
    G. De Mattia
    O. Laurenti
    A. Moretti
    Acta Diabetologica, 2009, 46
  • [34] Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
    Fonseca, V.
    Schweizer, A.
    Albrecht, D.
    Baron, M. A.
    Chang, I.
    Dejager, S.
    DIABETOLOGIA, 2007, 50 (06) : 1148 - 1155
  • [35] The dose response relationship of troglitazone in terms of triglycerides and glycaemic control in dyslipidaemic Type 2 diabetic patients
    Starkie, M
    Round, PM
    Home, PD
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 317 - 317
  • [36] Frequency of self-adjustment of insulin dose and metabolic control in Type 2 diabetes is there an association?
    Beluchin, E.
    Baez, L.
    Mueller, N.
    Lehmann, T.
    Kloos, C.
    Wolf, G.
    Mueller, U. A.
    DIABETIC MEDICINE, 2013, 30 (03) : E91 - E94
  • [37] Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data
    Peters, Anne
    Cohen, Nathan
    Calhoun, Peter
    Ruedy, Katrina J.
    Beck, Roy W.
    Martens, Thomas W.
    Bao, Shichun
    Njeru, Nelly M.
    Beck, Stayce E.
    Price, David A.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02) : 631 - 636
  • [38] Factors limiting glycaemic control in insulin treated type 2 diabetes
    Ferencz Vikotria
    Domjan Beatrix
    Gero Laszlo
    Tanczer Timea
    Tabak Gy Adam
    ORVOSI HETILAP, 2015, 156 (36) : 1443 - 1450
  • [39] The impact of insulin regimens and dose adjustment on glycaemic control in 21 centres
    Swift, P. G. F.
    de Beaufort, C. E.
    Danne, T.
    Skinner, C. T.
    Schoenle, E.
    DIABETOLOGIA, 2006, 49 : 560 - 561
  • [40] Authors' Reply to Gough: "Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes"
    Chatterjee, Sudesna
    Khunti, Kamlesh
    Davies, Melanie
    DRUGS, 2019, 79 (06) : 683 - 684
12345